UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 319

Sortiert nach

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer

Annals of oncology, 2004-03, Vol.15 (3), p.440-449

2004

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C

Annals of oncology, 2012-06, Vol.23 (6), p.1531-1536

2012

Link zum Volltext

Verfügbarkeit prüfen

Predicting 5-fluorouracil toxicity in colorectal cancer patients from peripheral blood cell telomere length: a multivariate analysis

British journal of cancer, 2012-10, Vol.107 (9), p.1525-1533

2012

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells

British journal of cancer, 2007-01, Vol.96 (2), p.231-240

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of pemetrexed disodium (ALIMTA®, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer

Annals of oncology, 2002-05, Vol.13 (5), p.737-741

2002

Link zum Volltext

Verfügbarkeit prüfen

Basis for effective combination cancer chemotherapy with antimetabolites

Pharmacology & therapeutics (Oxford), 2000-08, Vol.87 (2), p.227-253

2000

Link zum Volltext

Verfügbarkeit prüfen

The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine―oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer

British journal of cancer, 2012-01, Vol.106 (1), p.61-69

2012

Link zum Volltext

Verfügbarkeit prüfen

A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer

British journal of cancer, 2005-11, Vol.93 (11), p.1236-1243

2005

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study

Annals of oncology, 2016-07, Vol.27 (7), p.1273-1279

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparison of 5-fluoro-2′-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer

European Journal of Cancer, 1998-02, Vol.34 (3), p.296-306

1998

Link zum Volltext

Verfügbarkeit prüfen

Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel +/-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma

Annals of oncology, 2018-10, Vol.29, p.viii206-viii207

2018

Link zum Volltext

Verfügbarkeit prüfen

Thymidylate synthase inhibition induces S-phase arrest, biphasic mitochondrial alterations and caspase-dependent apoptosis in leukaemia cells

Cancer chemotherapy and pharmacology, 2000, Vol.46 (6), p.477-487

2000

Link zum Volltext

Verfügbarkeit prüfen

Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics

Annals of oncology, 2002-11, Vol.13 (11), p.1810-1818

2002

Link zum Volltext

Verfügbarkeit prüfen

High-dose methotrexate: a critical reappraisal

Journal of clinical oncology, 1987-12, Vol.5 (12), p.2017-2031

1987

Link zum Volltext

Verfügbarkeit prüfen

Dose-Intensive Epirubicin-Based Chemotherapy Is Superior to an Intensive Intravenous Cyclophosphamide, Methotrexate, and Fluorouracil Regimen in Metastatic Breast Cancer: A Randomized Multinational Study

Journal of clinical oncology, 2001-02, Vol.19 (4), p.943-953

2001

Link zum Volltext

Verfügbarkeit prüfen

Telomere length predicts neutrophil recovery in the absence of G-CSF after autologous peripheral blood stem cell transplantation

Bone marrow transplantation (Basingstoke), 2004-09, Vol.34 (5), p.439-445

2004

Link zum Volltext

Verfügbarkeit prüfen

Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivo

The pharmacogenomics journal, 2011-08, Vol.11 (4), p.307-314

2011

Link zum Volltext

Verfügbarkeit prüfen

Causes for increased myelosuppression with increasing age in patients with oesophageal cancer treated by chemoradiotherapy

European journal of cancer (1990), 1999-06, Vol.35 (6), p.921-927

1999

Link zum Volltext

Verfügbarkeit prüfen

Cantharimides: A new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A

Bioorganic & medicinal chemistry letters, 2001-11, Vol.11 (22), p.2941-2946

2001

Link zum Volltext

Verfügbarkeit prüfen

Haemolytic Uraemic Syndrome Associated with Bleomycin, Epirubicin and Cisplatin Chemotherapy: A Case Report and Review of the Literature

Acta oncologica, 1998, Vol.37 (1), p.107-109

Manon van der Heijden, Stephen P. Ackland, Sandra Deveridge

1998

Link zum Volltext

Verfügbarkeit prüfen

Simple and sensitive high-performance liquid chromatography method for the determination of docetaxel in human plasma or urine

Journal of chromatography. B, Biomedical sciences and applications, 2000-10, Vol.748 (2), p.383-388

2000

Link zum Volltext

Verfügbarkeit prüfen

Combined modality therapy for esophageal carcinoma: Preliminary results from a large Australasian multicenter study

International journal of radiation oncology, biology, physics, 1995-07, Vol.32 (4), p.997-1006

1995

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of vinflunine in patients with metastatic renal cell carcinoma

Investigational new drugs, 2006-09, Vol.24 (5), p.429-434

2006

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicin

Clinical pharmacology and therapeutics, 1989-04, Vol.45 (4), p.340-347

1989

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 319

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(290)
Mit Volltextzugriff
(279)

Publikationsform

Sprache

Englisch
(318)
Japanisch
(38)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(206)
Life Sciences & Biomedicine
(178)
Humans
(155)
Female
(94)
Biological And Medical Sciences
(81)
Male
(80)
Medical Sciences
(69)
Middle Aged
(69)
Aged
(63)
Oncology
(61)
Adult
(51)
Pharmacology. Drug Treatments
(37)
Animals
(33)
Chemotherapy
(29)
Physical Sciences
(26)
Pharmacology & Pharmacy
(25)
Tumors
(25)
Antineoplastic Agents
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(22)
Fluorouracil - Administration & Dosage
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer

Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C

Predicting 5-fluorouracil toxicity in colorectal cancer patients from peripheral blood cell telomere length: a multivariate analysis

Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells

Phase II trial of pemetrexed disodium (ALIMTA®, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer

Basis for effective combination cancer chemotherapy with antimetabolites

Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial

The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine―oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer

A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer

Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study

Comparison of 5-fluoro-2′-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer

Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel +/-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma

Thymidylate synthase inhibition induces S-phase arrest, biphasic mitochondrial alterations and caspase-dependent apoptosis in leukaemia cells

Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics

High-dose methotrexate: a critical reappraisal

Dose-Intensive Epirubicin-Based Chemotherapy Is Superior to an Intensive Intravenous Cyclophosphamide, Methotrexate, and Fluorouracil Regimen in Metastatic Breast Cancer: A Randomized Multinational Study

Telomere length predicts neutrophil recovery in the absence of G-CSF after autologous peripheral blood stem cell transplantation

Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivo

Causes for increased myelosuppression with increasing age in patients with oesophageal cancer treated by chemoradiotherapy

Cantharimides: A new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A

Haemolytic Uraemic Syndrome Associated with Bleomycin, Epirubicin and Cisplatin Chemotherapy: A Case Report and Review of the Literature

Simple and sensitive high-performance liquid chromatography method for the determination of docetaxel in human plasma or urine

Combined modality therapy for esophageal carcinoma: Preliminary results from a large Australasian multicenter study

Phase II study of vinflunine in patients with metastatic renal cell carcinoma

Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicin

Suchergebnisse filtern